FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of pharmaceutics, namely represents composition and method of increasing bioavailability of therapeutic agents in subject, as well as compositions and methods for providing pain relief in case of migraine. Compositions include at least one alkyl glycoside and at least one therapeutic agent, such as receptor 5-HT agonist, with alkyl glycoside length constituting from at least 10 to approximately 16 carbon atoms.
EFFECT: elaboration of method for increasing bioavailability of therapeutic agents in subject.
16 cl, 7 dwg, 16 tbl, 19 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS CONTAINING TRIPTANE COMPOUNDS | 2010 |
|
RU2710372C2 |
| COMPOSITIONS CONTAINING TRIPTANE COMPOUNDS | 2019 |
|
RU2762725C2 |
| COMPOSITIONS, DEVICES AND METHODS FOR THE TREATMENT OF ALCOHOL DEPENDENCE | 2017 |
|
RU2767062C2 |
| PEPTIDE DRUGS WITH HIGH EFFECTIVENESS AGAINST INSULIN RESISTANCE | 2012 |
|
RU2602801C2 |
| COMPOSITIONS AND METHODS OF TREATING OPIOID OVERDOSE | 2017 |
|
RU2769397C2 |
| IMPROVING ABSORPTION OF THERAPEUTIC AGENTS THROUGH MUCOUS MEMBRANES OR SKIN | 2009 |
|
RU2519193C2 |
| ACTIVE SUBSTANCE DELIVERY | 2008 |
|
RU2467741C2 |
| PHARMACEUTICAL COMPOSITIONS AND RELATED DELIVERY METHODS | 2009 |
|
RU2678833C2 |
| METHOD FOR PREVENTING GLP-1 SIDE EFFECTS | 2008 |
|
RU2474415C2 |
| DOSING MODES FOR ECHINOCANDINE CLASS COMPOUNDS | 2013 |
|
RU2639483C2 |
